Anti-C1S antibodies and methods of use thereof
US12391750B2 · kind B2 · utility
0Cited by
30References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2023 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Jul 7, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies that specifically bind complement pathway component C1s The present disclosure provides nucleic acids comprising nucleotide sequences encoding the anti-C1s antibodies; and host cells comprising the nucleic acids. The present disclosure provides compositions comprising the anti-C1s antibodies. The present disclosure provides methods of use of the anti-C1s antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.